According to Sun Pharmaceutical 's latest financial reports and stock price the company's current Operating Margin is 21.62%. At the end of 2023 the company had an Operating Margin of 22.14%.
Year | Operating Margin | Change |
---|---|---|
2023 | 22.14% | 84.57% |
2022 | 11.99% | 35.17% |
2021 | 8.87% | -45.88% |
2020 | 16.40% | 8.49% |
2019 | 15.11% | 0.22% |
2018 | 15.08% | -51.77% |
2017 | 31.27% | 23.76% |
2016 | 25.26% | 4.71% |
2015 | 24.13% | -16.16% |
2014 | 28.78% | -25.76% |
2013 | 38.76% | -8.37% |
2012 | 42.30% | 18.88% |
2011 | 35.58% | -1.82% |
2010 | 36.24% | -20.56% |
2009 | 45.62% | -4.25% |
2008 | 47.65% | 21.89% |
2007 | 39.09% | 7.2% |
2006 | 36.47% | 3.82% |
2005 | 35.13% | -9.28% |
2004 | 38.72% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.